GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (XBUL:AYJ) » Definitions » Accounts Payable & Accrued Expense

Valneva SE (XBUL:AYJ) Accounts Payable & Accrued Expense : лв92.3 Mil (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Valneva SE Accounts Payable & Accrued Expense?

Valneva SE's quarterly accounts payable & accrued expense declined from Sep. 2024 (лв117.0 Mil) to Dec. 2024 (лв78.3 Mil) but then increased from Dec. 2024 (лв78.3 Mil) to Mar. 2025 (лв92.3 Mil).

Valneva SE's annual accounts payable & accrued expense increased from Dec. 2022 (лв85.3 Mil) to Dec. 2023 (лв94.1 Mil) but then declined from Dec. 2023 (лв94.1 Mil) to Dec. 2024 (лв78.3 Mil).


Valneva SE Accounts Payable & Accrued Expense Historical Data

The historical data trend for Valneva SE's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valneva SE Accounts Payable & Accrued Expense Chart

Valneva SE Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 85.66 145.93 85.31 94.07 78.28

Valneva SE Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 95.99 92.50 116.96 78.28 92.34

Valneva SE Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


Valneva SE Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (XBUL:AYJ) » Definitions » Accounts Payable & Accrued Expense
Address
6 Rue Alain Bombard, Saint-Herblain, FRA, 44800
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Valneva SE Headlines

No Headlines